RiskMastery's Breakout Stocks - CYP EditionWelcome to RiskMastery's Breakout Stocks - Stocks with breakout potential.
In this edition, we'll be looking at ASX:CYP ...
I believe this code is at a point of potential volatility.
If price can hold above $0.200 ... Bullish potential may be unlocked.
My key upside targets include:
-
Next report date
Report period
H2 2024
EPS estimate
—
Revenue estimate
—
−0.0596USD
−9.51 MUSD
154.32 M
About CYNATA THERAPEUTICS LIMITED
Sector
Industry
CEO
Kilian Kelly
Website
Headquarters
Cremorne
Founded
2003
ISIN
AU000000CYP7
FIGI
BBG008P6RRX6
Cynata Therapeutics Ltd. engages in the development and commercialization of therapeutic products. It focuses on proprietary mesenchymal stem cell technology. The company was founded on March 12, 2003 and is headquartered in Carlton, Australia.
Broken trend now looking for run higherDowntrend was broken at the start of the month with good volume but yet to really offer big breakout. Looking for a fill up to 0.775 (resistance from early jan). Once past that, not much stopping it up to 0.870 or higher.
Stop at 0.655 which looks like a base
RSI has plenty of room run
CYP - Technical Bullish Flag + CV TailwindsClassic bullish flag forming in the Cynata Therapeutics chart. Not the best time for the technicals to line up as far as the overall market in concerned, but this looks to be High probabilty trade on the back of their cv19 tailwinds/fundamentals as they turn their attention to virus treatments (cv19
$CYP - CYNATA - Up or Down ?Cynata has been having a good run of late, but is back up against its previous all time high. If it can push through I would take a punt on it to continue. It hit $1.65 in todays early trade but back down to $1.52 now. One to watch for now.
Cynata Therapeutics Limited is a stem cell and regenerativ
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of CYYNF is 0.1100 USD — it has increased by 52.78% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Cynata Therapeutics Ltd. stocks are traded under the ticker CYYNF.
Cynata Therapeutics Ltd. is going to release the next earnings report on Aug 22, 2024. Keep track of upcoming events with our Earnings Calendar.
CYYNF stock is 34.55% volatile and has beta coefficient of −0.01. Check out the list of the most volatile stocks — is Cynata Therapeutics Ltd. there?
CYYNF earnings for the last quarter are −0.02 USD per share, whereas the estimation was −0.03 USD resulting in a 37.75% surprise. The estimated earnings for the next quarter are −0.03 USD per share. See more details about Cynata Therapeutics Ltd. earnings.
Cynata Therapeutics Ltd. revenue for the last quarter amounts to 5.06 M USD despite the estimated figure of 3.05 M USD. In the next quarter revenue is expected to reach 2.90 M USD.
Yes, you can track Cynata Therapeutics Ltd. financials in yearly and quarterly reports right on TradingView.
CYYNF net income for the last quarter is −3.09 M USD, while the quarter before that showed −6.06 M USD of net income which accounts for 49.02% change. Track more Cynata Therapeutics Ltd. financial stats to get the full picture.
Today Cynata Therapeutics Ltd. has the market capitalization of 24.43 M, it has decreased by 2.01% over the last week.
No, CYYNF doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, CYYNF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Cynata Therapeutics Ltd. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Cynata Therapeutics Ltd. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Cynata Therapeutics Ltd. stock shows the sell signal. See more of Cynata Therapeutics Ltd. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.